Gaps in the cascade of care contribute to poor liver cancer outcomes among people living with hepatitis B: a prospective longitudinal cohort study
This prospective longitudinal cohort study in Victoria, Australia, reveals that despite effective antiviral therapies, gaps in the hepatitis B care cascade—specifically low treatment uptake and missed cirrhosis diagnoses—continue to drive poor liver cancer outcomes among a significant proportion of patients.